Continue Reading
Full article on CNBC
OpenEvidence, the 'ChatGPT for doctors,' doubles valuation to $12 billion
Market Intelligence Analysis
AI-Powered
Why This Matters
OpenEvidence, a Massachusetts-based healthcare technology company, has doubled its valuation to $12 billion following a funding round led by Thrive and DST.
Market Impact
Market impact analysis based on bullish sentiment with 90% confidence.
Sentiment
Bullish
AI Confidence
90%
Time Horizon
Short Term
Article Context
Note: This is a brief excerpt for context. Click below to read the full article on the original source.
OpenEvidence, based in Massachusetts, has topped a $12 billion valuation in a funding round led by Thrive and DST.
Original article published by
CNBC
on January 21, 2026.
Analysis and insights provided by AnalystMarkets AI.
Analysis and insights provided by AnalystMarkets AI.